Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,468 | -48,481 | -43,773 | -175,850 | -119,868 |
| Depreciation Amortization | 1,534 | 1,023 | 504 | 1,987 | 1,484 |
| Accounts receivable | -25,506 | -24,624 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -674 | -2,603 | -3,336 | 5,672 | 3,094 |
| Other Working Capital | -18,218 | -24,773 | -6,356 | 6,018 | 3,409 |
| Other Operating Activity | 63,426 | 54,098 | 20,209 | 93,077 | 66,776 |
| Operating Cash Flow | $-1,906 | $-45,360 | $-32,752 | $-69,096 | $-45,105 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -14 | -5 | -218 | -210 |
| Purchase Of Investment | -267,936 | -104,764 | -45,358 | -356,464 | -308,915 |
| Sale Of Investment | 191,530 | 119,800 | 68,300 | 131,000 | 77,000 |
| Investing Cash Flow | $-76,421 | $15,022 | $22,937 | $-225,682 | $-232,125 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 49,888 | N/A |
| Common Stock Issued | 237,156 | 19,180 | 3,280 | 163,137 | 155,962 |
| Other Financing Activity | -95 | -273 | -62 | 0 | 0 |
| Financing Cash Flow | $237,061 | $18,907 | $3,218 | $213,025 | $155,962 |
| Beginning Cash Position | 87,928 | 87,928 | 87,928 | 169,681 | 169,681 |
| End Cash Position | 246,662 | 76,497 | 81,331 | 87,928 | 48,413 |
| Net Cash Flow | $158,734 | $-11,431 | $-6,597 | $-81,753 | $-121,268 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,906 | -45,360 | -32,752 | -69,096 | -45,105 |
| Capital Expenditure | -15 | -14 | -5 | -218 | -210 |
| Free Cash Flow | -1,921 | -45,374 | -32,757 | -69,314 | -45,315 |